VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NBTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksNBTXInstitutional Holders

NBTX logoNanobiotix S.A. (NBTX) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership increased this quarter (+0.19 pp), though top 10 holders maintain a highly concentrated 99.9% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
11.5%$217M total value · ▲ +0.19 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
60 / 100Bullish
Institutions & Flow19 holders+3 net flow (+6 / -3)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+3)
  • Jane Street Group, Llc and Citadel Advisors Llc maintain significant positions
  • Top 10 holders control 99.9% of institutional value
  • No Insider Signal

Top Institutional Holders of NBTX

Ranked by reported Q2 2026 13F market value

Top 10 Holders
99.9%
Top 25 Holders
100.0%

Share of total reported institutional value in NBTX held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1JOHNSON & JOHNSON5.6M$212.0M0.0%11.115%26.55%
2MORGAN STANLEY50K$1.9M+37.3%0.098%0.00%
3JANE STREET GROUP, LLC

Quarterly Institutional Activity

Filings activity in NBTX during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers6Added To10Trimmed2Exited3
  • UBS Group AG$97K
  • RHUMBLINE ADVISERS$57K

NBTX Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 202619+27%11.45%+0.19 pp$217M+24%
Q1 202615+7.1%11.26%0.01 pp$176M+33%
Q4 202514+27%11.27%+0.11 pp$132M+24%
Q3 202511+0.0%11.16%+0.00 pp$107M+317%
Q2 20251115%11.16%0.23 pp$26M+24%
Q1 20251332%

How NBTX Compares to Peers

Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
DMRADamora Therapeutics, Inc.$1.46B200.0%99+33
FTHFaeth Therapeutics, Inc.$568M54.5%45+16
LONALeonaBio, Inc.$17M184.4%45+4
KYNBKyntra Bio, Inc.$15M26.9%29-4
CNSYCerenome, Inc.$5M4.8%24-5

NBTX — Frequently Asked Questions

Quick answers to the most common questions about buying NBTX stock.

What percentage of NBTX is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Nanobiotix S.A. stands at 11.5%, held across 19 reporting institutions.

Who is the largest institutional holder of NBTX?

JOHNSON & JOHNSON is the largest reported institutional holder of NBTX, with approximately 5,623,816 shares worth $0.21B as of Q2 2026.

Is NBTX a hedge fund favorite?

Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of NBTX, including JANE STREET GROUP, LLC, CITADEL ADVISORS LLC.

What is NBTX's Smart Money Score?

Our composite Smart Money Score for NBTX is 60 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought NBTX this quarter?
32K
$1.2M
—
0.064%
0.00%
4XTX Topco Ltd16K$598K—0.031%0.01%
5Optiver Holding B.V.14K$514K+1.0%0.027%0.00%
6MARSHALL WACE, LLP10K$379K+8.7%0.020%0.00%
7CITADEL ADVISORS LLC6K$228K—0.012%0.00%
8BNP PARIBAS FINANCIAL MARKETS4K$152K+13.6%0.008%0.00%
9UBS Group AG3K$97K-53.6%0.005%0.00%
10ROYAL BANK OF CANADA2K$83K+20.0%0.004%0.00%
11JPMORGAN CHASE & CO2K$61K—0.003%0.00%
12RHUMBLINE ADVISERS2K$57K-34.2%0.003%0.00%
13GAMMA Investing LLC985$37K+19.0%0.002%0.00%
14OSAIC HOLDINGS, INC.500$19K0.0%0.001%0.00%
15WELLS FARGO & COMPANY/MN200$8K0.0%0.000%0.00%
16Stone House Investment Management, LLC76$3K—0.000%0.00%
17Federation des caisses Desjardins du Quebec56$2K—0.000%0.00%
18HRT FINANCIAL LP27K$1K—0.054%0.00%
19NATIONAL BANK OF CANADA /FI/13$4820.0%0.000%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in NBTX — a direct measure of their conviction.

11.39%
0.60 pp
$21M
+18%
Q4 202419+73%11.99%0.69 pp$17M53%
Q3 202411—12.68%—$37M—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

6 institutions opened new positions in NBTX during Q2 2026, while 3 fully exited. 10 added to existing positions and 2 trimmed.

How is institutional ownership of NBTX changing?

NBTX institutional ownership rose by 0.19 percentage points quarter-over-quarter, with a net change of +4 holders.

How concentrated is NBTX ownership among the top holders?

The top 10 institutions account for 99.9% of all reported 13F value in NBTX, and the top 25 account for 100.0%.

How does NBTX compare to Oncology Biotech on institutional ownership?

Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.

Where does this NBTX institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

NBTXNanobiotix S.A.
$26.90$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership